In recognition of #WorldDiabetesDay, we’re revisiting this #HowCellsWork episode, which looks at how immune tolerance therapies could change the treatment paradigm for #Type1Diabetes & improve patient quality of life. Cc @JDRF
About 70% of oropharyngeal cancers are linked to human papillomavirus (HPV). In this #HowCellsWork episode, we explore how #HPV can cause #headandneckcancer:
#Clinicaltrials are research studies that test whether new therapies for diseases like #cancer are safe & effective. But how do they work? In this #HowCellsWork episode, we explore the different trial phases & explain how new treatments are evaluated and potentially approved:
TIL therapies have shown potential for impact across multiple solid tumors, but one challenge is the use of IL-2 administration to support TIL function. Our latest #HowCellsWork story illustrates this challenge and potential solutions that could improve patient outcomes. #SITC21
Checkpoint Inhibitors (CPIs) are an important immuno-therapy approach for patients with certain cancers. In this #HowCellsWork story, we examine how different types of CPIs work to allow T cells to attack tumors. Check out our cell stories here: bit.ly/3jEjPww
Celiac disease is a chronic immune mediated disease that impacts millions of patients around the world. In this #HowCellsWork story we break down how the disease may be overcome through immune tolerance therapeutic approaches. #CeliacAwarenessDay@celiacdotorg@beyondceliac
In this final episode of our #HowCellsWork#ImmunoOncology animation series, we explore how scientists have tried to engineer dendritic cells, the generals of the immune system.
Thanks for following our #HowCellsWork#ImmunoOncology animation series. In this 3rd episode we move from T and NK cells to their hungry cousin, Macrophages.
Thanks for following our #HowCellsWork#immunooncology animation series. In this episode we move from T cells to their cousins, Natural Killer, or NK cells, and some ways they are being engineered to attack tumors.
In this episode of #HowCellsWork, we look at how patient T cells can be used to generate TIL, TCR, and CAR-T therapies to fight a tumor. Stay tuned for our next episode in two weeks, when we look at NK cells!
@SQZbiotech launches its immuno-oncology #HowCellsWork series. Every two weeks we will cover a different cell type. Our first episode this week is on the mighty T cells.